Citations

Clear

554 citation(s) found for "Li, Gerald".

The consequences of not having eosinophils
Gleich, Gerald J. , Klion, Amy D. , Lee, J. J., Weller, Peter F. , Klion, Amy D

Mayo Clinic

Allergy | June 6, 2013 | Volume: 68 | Issue: 7 | Pages: 829-835

10.1111/all.12169 | PMID 23742015 Get It

AbstractSeveral lines of evidence suggest that deficiency of eosinophils is not associated with any characteristic abnormality. Patients lacking eosinophils, in the setting of immunodeficiency or as a consequence of IgG‐mediated eosinophil precursor destruction, do not display any distinguishing abnormalities related to eosinophil reduction. The observation that eosinophil‐deficient mice do not display any distinctive syndrome or failure of their health is evidence that, under ordinary laboratory conditions, the eosinophil does not play a critical role in the well‐being of mammals. Observations that monoclonal antibodies to interleukin‐5 (IL‐5) are well tolerated appear unsurprising in light of these findings. For example, patients with the hypereosinophilic syndrome have received mepolizumab, an anti‐IL‐5 monoclonal antibody, for as long as 6 years and have not developed any characteristic set of adverse events. Safety data for reslizumab, another anti‐IL‐5 monoclonal antibody, and benralizumab, a monoclonal antibody to the IL‐5 receptor α‐chain, are comparatively limited, especially for benralizumab, although reports of administration of these antibodies to humans suggest that they are well tolerated. Thus, data to the present suggest that reduction of eosinophils appears to have no characteristic ill effects on normal health, and monoclonal antibodies that deplete eosinophils have the potential to be widely employed in the treatment of eosinophil‐associated diseases.
Premature Cardiac Contractions and Risk of Incident Ischemic Stroke
Ofoma, Uchenna R. , He, Fan , Shaffer, Michele L. , Naccarelli, Gerard V., Liao, Duanping , Ofoma, Uchenna, Naccarelli, Gerald V. , Ofoma, Uchenna R

Mayo Clinic

Journal of the American Heart Association | May 24, 2013 | Volume: 1 | Issue: 5 | Pages: No page available

10.1161/jaha.112.002519 | PMID 23316293 Get It

Background The etiologies of ischemic stroke remain undetermined in 15% to 40% of patients. Apart from atrial fibrillation, other arrhythmias are less well‐characterized as risk factors. Premature cardiac contractions are known to confer long‐term cardiovascular risks, like myocardial infarction. Ischemic stroke as cardiovascular risk outcome remains a topic of interest. We examined the prospective relationships in the Atherosclerosis Risk in Communities ( ARIC ) study, to determine whether premature atrial ( PAC ) or ventricular ( PVC ) contractions are associated with increased risk for incident ischemic stroke. Methods and Results We analyzed 14 493 baseline stroke‐free middle‐aged individuals in the ARIC public‐use data. The presence of PAC or PVC at baseline was assessed from 2‐minute electrocardiogram. A physician‐panel confirmed and classified all stroke cases. Average follow‐up time was 13 years. Proportional hazards models assessed associations between premature contractions and incident stroke. PAC s and PVC s were identified in 717 (4.9%) and 793 (5.5%) participants, respectively. In all, 509(3.5%) participants developed ischemic stroke. The hazard ratio ( HR ) (95% confidence interval [ CI ]) associated with PVC was 1.77 (1.30, 2.41), attenuated to 1.25 (0.91, 1.71) after adjusting for baseline stroke risk factors. The interaction between PVC and baseline hypertension was marginally significant ( P =0.08). Among normotensives, having PVC s was associated with nearly 2‐fold increase in the rate of incident ischemic stroke ( HR 1.69; 95% CI 1.02, 2.78), adjusting for stroke risk factors. The adjusted risk of ischemic stroke associated with PAC s was 1.30 (95% CI 0.92, 1.83). Conclusions Presence of PVC s may indicate an increased risk of ischemic stroke, especially in normotensives. This risk approximates risk of stroke from being black, male, or obese in normotensives from this cohort.
Tadalafil once daily in the treatment of lower urinary tract symptoms ( LUTS ) suggestive of benign prostatic hyperplasia ( BPH ) in men without erectile
Brock, Gerald, Broderick, Gregory A. , Roehrborn, Claus G. , Xu, Lei , Wong, David , Viktrup, Lars

Mayo Clinic

BJU International | May 23, 2013 | Volume: 112 | Issue: 7 | Pages: 990-997

10.1111/bju.12251 | PMID 23937669 Get It

Objectives To assess the safety and efficacy of tadalafil once daily on lower urinary tract symptoms suggestive of clinical benign prostatic hyperplasia ( BPH‐LUTS ) in men without erectile dysfunction ( ED ). To compare these with effects in men with ED . Patients and Methods After a 4‐week washout period and 4‐week placebo run‐in period, 1089 men without ED ( n = 338) and with ED ( n = 751) were randomly assigned to placebo or tadalafil 5 mg once daily for 12 weeks in three global clinical studies with similar designs. In the pooled dataset, post hoc analyses of covariance assessed the impact and severity of BPH‐LUTS using the I nternational P rostate S ymptom S core ( IPSS ) and the BPH I mpact I ndex ( BII ) and IPSS quality‐of‐life ( IPSS ‐ QoL ) subscores. Safety was assessed using treatment‐emergent adverse events. The treatment‐by‐ ED ‐status interaction was used to assess efficacy differences between the with/without ED subgroups. Results Men without ED were similar in BPH‐LUTS severity/previous therapy to men with ED . Tadalafil significantly reduced BPH‐LUTS from baseline when compared with placebo in men without ED ( IPSS −5.4 vs −3.3, P < 0.01; IPSS voiding subscore −3.5 vs −2.0, P < 0.01; IPSS storage subscore −1.9 vs −1.3, P < 0.05). Tadalafil also significantly improved quality of life from baseline when compared with placebo in men without ED ( IPSS ‐ QoL −1.0 vs −0.7, BII −1.4 vs −1.0; both P < 0.05). Between‐ ED ‐subgroup interactions were not significant (all P > 0.68). Tadalafil was safe and well tolerated. Conclusion Tadalafil 5 mg once daily improved BPH‐LUTS in men without ED by a magnitude similar to that observed in men with ED . The adverse event profile in men without ED was consistent with that observed in men with ED .
Training Mid-level Providers on Palliative Care
Lesperance, Mary, Shannon, Robert P. , Pumphrey, Phyllis K., Dunbar, Erin, Genther, Renee, Coleman, C. Lynn, Tabano, Margaret, Maurer, Jennifer, Vazquez, Adrienne Marie, Capp, Elizabeth, McMillan, Jessica , Wilkerson, Katie, Robbins, Gerald, Phillips, Dorothy Green, Howick, Priscilla H., Solaun, Catherine, Sloan, Jeff A. , Colón‐Otero, Gerardo

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | April 24, 2013 | Volume: 31 | Issue: 3 | Pages: 237-243

10.1177/1049909113486335 | PMID 23616274 Get It

Palliative care services are not available in most outpatient oncology practices. A program training 11 mid-level providers from oncology practices on advanced directive discussions and supportive symptom assessment and management performed by palliative care specialists was completed. A follow-up session 9 months later identified barriers to implementation. Of the 11 mid-level providers, 8 participated in the follow-up session, and 9 of the 11 providers implemented advanced directive’s discussions and symptom assessment and management for patients with metastatic cancer. Main barriers included uncertainties about reimbursement, patients’ lack of knowledge about palliative care, and lack of access to supportive services. This program successfully promoted advanced directive discussions and supportive/palliative care symptom assessment and management to community oncology practices, which will hopefully translate into improved quality of life for patients with metastatic cancer.
Interferon-α Treatment of Six Patients with the Idiopathic Hypereosinophilic Syndrome
Butterfield, Joseph H. , Gleich, Gerald J., Gleich, Gerald J.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 121 | Issue: 9 | Pages: 648-653

10.7326/0003-4819-121-9-199411010-00003 | PMID 7944072 Get It

Cytokine Production at the Site of Disease in Chronic Eosinophilic Pneumonitis
Kita, H., Sur, Sanjiv , Hunt, Loren W., Edell, Eric S. , Weiler, Deborah A., Swanson, Mark C., Samsel, R. W., Abrams, J S, Gleich, Gerald J. , Kita, Hirohito , Kita, H

Mayo Clinic

American journal of respiratory and critical care medicine | April 4, 2013 | Volume: 153 | Issue: 4 | Pages: 1437-1441

10.1164/ajrccm.153.4.8616578 | PMID 8616578 Get It

Abstract Chronic eosinophilic pneumonitis (CEP) is characterized by longstanding respiratory symptoms accompanied by a massive pulmonary eosinophil infiltration. We hypothesized that cytokine(s) produced in the disease sites are implicated in the pathophysiology of CEP. We studied peripheral blood and bronchoalveolar lavage fluids (BALF) obtained from two lung segments of a patient with CEP. Seventy times more eosinophils were found in the BALF from an involved lung segment (showing patchy opacification on a chest roentgenogram) than from an uninvolved segment. The eosinophil-active cytokines interleukin-5 (IL-5), IL-6, and IL-10 were strikingly elevated in the BALF from the involved lung segment, whereas no or minimal levels of these cytokines were detectable in the BALF from the uninvolved segment or serum, respectively. Leukocytes in the involved lung segment, but not those in peripheral blood, expressed messenger ribonucleic acid (mRNA) for IL-5, IL-6, and IL-10. In contrast, IL-2, IL-3, IL-4, interferon-gamma (IFN-gamma), granulocyte-macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor-alpha (TNF-alpha) were not detected in any sample. These findings suggest that increased production of several cytokines, such as IL-5, IL-6, and IL-10, in the involved lung segment, but not in the uninvolved lung segment or peripheral blood, is a critical pathophysiologic feature of CEP.
Endotoxin Contamination Causes Neutrophilia Following Pulmonary Allergen Challenge
Hunt, Loren W., Gleich, Gerald J. , Ohnishi, Toshio , Weiler, Deborah A., Mansfield, Elaine, Kita, Hirohito , Sur, Sanjiv , Kita, H

Mayo Clinic

American journal of respiratory and critical care medicine | April 4, 2013 | Volume: 149 | Issue: 6 | Pages: 1471-1475

10.1164/ajrccm.149.6.8004300 | PMID 8004300 Get It

Abstract Segmental bronchoprovocation (SBP) with allergen was used in an attempt to study eosinophils recruited to the airway 24 h after challenge. Unexpectedly, in the first four patients, neutrophils (rather than eosinophils) were recruited in the bronchoalveolar lavage (BAL) fluids, and we hypothesized that the allergen extracts were contaminated with endotoxin. The extracts used for challenge in the first four patients tested positive for bacterial endotoxin in a limulus amebocyte lysate assay. Rechallenge of one patient from the first group with a comparable dose of an endotoxin-free extract and SBP with endotoxin-free extract in five additional patients resulted in preferential recruitment of eosinophils rather than neutrophils. The number of neutrophils recovered from the challenged segments in the patients challenged with endotoxin-free extract was significantly less than that observed in the first four patients. Taken together, these observations suggest that neutrophil recruitment in the 24-h BAL fluids from the first four patients was probably due to endotoxin contamination of the allergen extract. We caution investigators that endotoxin contamination of allergen extract may alter the cellular inflammation during the late airway response following allergen challenge.
Increased Airway Inflammation with Segmental versus Aerosol Antigen Challenge
Calhoun, William J. , Jarjour, Nizar N. , Gleich, Gerald J. , Stevens, Carol A., Fahy, John V. , Busse, William W.

Mayo Clinic

American Review of Respiratory Disease | April 4, 2013 | Volume: 147 | Issue: 6_Part_1 | Pages: 1465-1471

10.1164/ajrccm/147.6_pt_1.1465 | PMID 8389107 Get It

Abstract Airway inflammation is increasingly recognized as a pivotal component of asthma. Because allergens provoke bronchial constriction and inflammation in allergic subjects, bronchial antigen challenge has emerged as a powerful technique for evaluating mechanisms involved in this process. In this study, we compare whole lung antigen challenge (WLAC) with segmentai bronchoprovocation (SBP) in eight allergic, non-asthmatic, non-smoking subjects, and evaluated the response by bronchoalveolar lavage (BAL) prior to, and 48 h after antigen challenge. Both challenge techniques evoked airway inflammation, manifest as an increase in total cells and eosinophils recovered by BAL, an increase in total protein concentration, and enhanced production of superoxide anion by airspace cells. The degree to which these changes occurred was significantly greater with SBP than WLAC, and only SBP evoked persistent measurable change in alveolar macrophage density and eosinophil granule protein concentrations. Moreover, although both techniques were associated with a comparable immediate fall in FEV1, only WLAC resulted in statistically significant persistent physiologic changes 48 h afterwards. We conclude that, as anticipated, SBP produces more intense airway inflammation in allergic subjects, does not result in late airway obstruction, and offers specific advantages in studying allergen-driven airway inflammation.
IL-5 Is the Predominant Eosinophil-active Cytokine in the Antigen-induced Pulmonary Late-phase Reaction
Ohnishi, Toshio , Kita, Hirohito , Weiler, D., Sur, Sanjiv , Sedgwick, J.B., Calhoun, William J. , Abrams, J S, Gleich, Gerald J. , Busse, William W. , Kita, H

Mayo Clinic

American Review of Respiratory Disease | April 4, 2013 | Volume: 147 | Issue: 4 | Pages: 901-907

10.1164/ajrccm/147.4.901 | PMID 8466126 Get It

Abstract The mechanism of airway eosinophilia during antigen-induced inflammation was investigated by measurement of eosinophil-active cytokines utilizing an eosinophil survival assay. In the first study, 4 patients with allergic rhinitis underwent segmental bronchoprovocation (SBP) with low, medium, and high doses of ragweed extract instilled into different bronchial subsegments; bronchoalveolar lavage (BAL) fluids were collected from each segment 12 min and 48 h after challenge. Eosinophil granule proteins and eosinophil survival activity were significantly elevated in the 48-h (late-phase) BAL fluids from these segments. Correlations were observed between the concentrations of eosinophil granule proteins and eosinophil survival activity (rs = 0.717 to 0.880, p &lt; 0.001) in BAL fluids. Eosinophil survival activity was completely neutralized by anti-IL-5 monoclonal antibody in five of the seven 48-h samples tested representing three of the 4 patients. In the two remaining samples, eosinophil survival activity was only partially neutralized by either anti-IL-5 antibody or anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) but was completely neutralized by anti-IL-5 and anti-GM-CSF in combination. Subsequently, in the second study, 10 patients with allergic rhinitis were challenged by SBP with ragweed extract. Eosinophil survival activity was significantly elevated in the 48-h BAL fluids; this activity was partially neutralized by anti-IL-5 antibody about (48%) and completely neutralized by the combination of anti-IL-5 and anti-GM-CSF antibodies. These findings suggest that the eosinophil survival activity in the late inflammatory lesions following SBP with allergen is mainly associated with IL-5, with small contributions from GM-CSF. Thus, IL-5 is the predominant eosinophil-active cytokine present in BAL fluids during allergen-induced late-phase inflammation and may play a key role in the pathophysiology of allergen-induced, eosinophil-predominant airway inflammation.
Immunoglobulin E-mediated Increase in Vascular Permeability Correlates with Eosinophilic Inflammation
Collins, Donald S., Dupuis, Richard, Gleich, Gerald J. , Bartemes, Kathleen R. , Koh, Young Yull, Pollice, Mary, Albertine, Kurt H. , Fish, James E., Peters, Stephen P.

Mayo Clinic

American Review of Respiratory Disease | April 4, 2013 | Volume: 147 | Issue: 3 | Pages: 677-683

10.1164/ajrccm/147.3.677 | PMID 8442605 Get It

Abstract An increase in bronchovascular permeability is thought to play an important role in the pathogenesis of allergic asthma. We sought to determine whether the increase in permeability observed 24 h after segmental antigen challenge in ragweed-allergic human volunteers was associated with the infiltration and degranulation of a specific cell type. A 20,000-fold range of antigen concentrations was used to alter the number and type of inflammatory cells recruited to the lung by challenge. Although large numbers of inflammatory cells were recruited to lung air spaces over a large range of antigen concentrations, significant numbers of eosinophils (731.3 ± 232.9 × 103/ml) were recruited only when the concentration of antigen used for segmental challenge was ⩾ 100-fold higher than the concentration needed to produce an 8 to 10 mm wheal 20 min after intradermal skin testing. In addition, large increases in bronchoalveolar lavage (BAL) albumin concentration (636.3 ± 170.5 µg/ml) were observed only in this same group of subjects. The correlation coefficient between the logarithms of the BAL eosinophil concentration and albumin concentration was +0.82 (p &lt; 0.001), and between eosinophil-derived neurotoxin and albumin it was +0.88 (p &lt; 0.001). In a stepwise, multiple regression analysis, eosinophils accounted for 67% of the variance in BAL albumin concentration, whereas no other cell type was a significant predictor of albumin flux into BAL fluid. We conclude that eosinophil recruitment and degranulation are associated with large increases in bronchovascular permeability after segmental antigen challenge in humans.